Hunan Hansen Pharmaceutical Co.,Ltd.’s Net Profit Rose 14.6% in First Three Quarters of 2022

Hunan Hansen Pharmaceutical Co.,Ltd. (湖南汉森制药股份有限公司) (002412.SZ) reported a net profit of 130.1 million yuan in the first three quarters of 2022, up 14.6% year-on-year.

Meanwhile, the company posted 681.2 million yuan in revenue, up 3.2% year-on-year.

At the end of the reporting period, it had 2.3 billion yuan in total assets and 455 million yuan in total liabilities, with a liability-to-asset ratio of 19.6%.